-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
LakeShore Biopharma Co., Ltd. quarterly Assets history and growth rate from Q1 2023 to Q1 2024.
- LakeShore Biopharma Co., Ltd. Assets for the quarter ending March 31, 2024 was $213M, a 14.8% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)